FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386006145> ?p ?o ?g. }

• W4386006145 endingPage "41" @default.
• W4386006145 startingPage "1" @default.
• W4386006145 abstract "Abstract Molecular studies, as well as epidemiological observation, support the concept of distinct molecular pathways to melanoma, suggesting that there are different melanoma subtypes with different biological aggressiveness, kinetics and prognosis. The incidence of melanoma is still rising worldwide, despite sun‐protection campaigns. Although sun exposure is considered as the main risk factor, genetics may play the significant role, not only in familial forms but also in apparently sporadic cases that may result from a chance combination of many low susceptibility genes. Mortality, at best, has plateaued despite earlier detection in the high‐risk population under dermatological surveillance. Indeed, most aggressive melanomas may develop in this population, suggesting that education to self‐detection should target the whole community. Melanoma detection remains a clinical challenge based on cognitive, comparative and dynamic recognition. Pigmented lesions suspicious for melanoma on the basis of history or physical examination warrant appropriate biopsy and histopathological diagnosis. Most melanoma is clinically localized to the primary site and requires definitive treatment with wide local excision with an appropriate margin. As the most frequent site of first metastasis is the regional nodal basin, consideration should also be given to sentinel lymph node biopsy in the correct clinical context. The treatment of advanced melanoma is in a very dynamic state of change. After years of standstill, melanoma has evolved into a paradigm for precision medicine based on substantial progress in molecular biology and tumour immunology. Both immunotherapy using anti‐checkpoint antibodies such as anti‐CTLA‐4 or anti‐PD‐1 antibodies and targeted therapy including BRAF inhibitors and mitogen extracellular kinase inhibitors are able to improve the prognosis of melanoma patients. Treatment decisions in melanoma patients are based on the basic prognostic parameters such as tumour thickness, involvement of the regional lymph nodes, extent of internal organ involvement with special attention to brain metastases, growth dynamics and, in addition, on the molecular assessment of the tumour concerning mutations (in particular BRAF and NRAS mutations) that facilitate the use of selective small kinase inhibitors. In order to support this rapid development, patients with advanced disease should be referred to tertiary skin cancer centres that can offer clinical trial participation." @default.
• W4386006145 created "2023-08-20" @default.
• W4386006145 creator A5008000580 @default.
• W4386006145 creator A5040001354 @default.
• W4386006145 creator A5049283041 @default.
• W4386006145 creator A5049455638 @default.
• W4386006145 creator A5064487000 @default.
• W4386006145 creator A5068146420 @default.
• W4386006145 creator A5089297467 @default.
• W4386006145 date "2016-10-09" @default.
• W4386006145 modified "2023-10-12" @default.
• W4386006145 title "Melanoma" @default.
• W4386006145 cites W1007020280 @default.
• W4386006145 cites W1270711560 @default.
• W4386006145 cites W1486574296 @default.
• W4386006145 cites W1501257267 @default.
• W4386006145 cites W1502182522 @default.
• W4386006145 cites W1506082933 @default.
• W4386006145 cites W1516437155 @default.
• W4386006145 cites W1554373823 @default.
• W4386006145 cites W1582060476 @default.
• W4386006145 cites W1595354180 @default.
• W4386006145 cites W1595732636 @default.
• W4386006145 cites W1596863820 @default.
• W4386006145 cites W1597791301 @default.
• W4386006145 cites W1713788206 @default.
• W4386006145 cites W1820264760 @default.
• W4386006145 cites W1828940258 @default.
• W4386006145 cites W1845814451 @default.
• W4386006145 cites W1891974901 @default.
• W4386006145 cites W1908752382 @default.
• W4386006145 cites W1943557071 @default.
• W4386006145 cites W1950572133 @default.
• W4386006145 cites W1964595836 @default.
• W4386006145 cites W1965370740 @default.
• W4386006145 cites W1965572343 @default.
• W4386006145 cites W1965593856 @default.
• W4386006145 cites W1966238809 @default.
• W4386006145 cites W1967370147 @default.
• W4386006145 cites W1969401815 @default.
• W4386006145 cites W1970051943 @default.
• W4386006145 cites W1971050728 @default.
• W4386006145 cites W1973552654 @default.
• W4386006145 cites W1976459566 @default.
• W4386006145 cites W1977874158 @default.
• W4386006145 cites W1978113416 @default.
• W4386006145 cites W1978678832 @default.
• W4386006145 cites W1979188393 @default.
• W4386006145 cites W1979501070 @default.
• W4386006145 cites W1979580952 @default.
• W4386006145 cites W1980262236 @default.
• W4386006145 cites W1980974844 @default.
• W4386006145 cites W1981605211 @default.
• W4386006145 cites W1981893715 @default.
• W4386006145 cites W1982002584 @default.
• W4386006145 cites W1983079102 @default.
• W4386006145 cites W1983139163 @default.
• W4386006145 cites W1983751803 @default.
• W4386006145 cites W1985198734 @default.
• W4386006145 cites W1986793246 @default.
• W4386006145 cites W1986987499 @default.
• W4386006145 cites W1987822477 @default.
• W4386006145 cites W1989121777 @default.
• W4386006145 cites W1989796306 @default.
• W4386006145 cites W1990029546 @default.
• W4386006145 cites W1994123826 @default.
• W4386006145 cites W1995382314 @default.
• W4386006145 cites W1997650822 @default.
• W4386006145 cites W1998147375 @default.
• W4386006145 cites W1998911548 @default.
• W4386006145 cites W1998938134 @default.
• W4386006145 cites W1999872884 @default.
• W4386006145 cites W1999985524 @default.
• W4386006145 cites W2000117915 @default.
• W4386006145 cites W2000292536 @default.
• W4386006145 cites W2001378671 @default.
• W4386006145 cites W2001894998 @default.
• W4386006145 cites W2003078451 @default.
• W4386006145 cites W2003312762 @default.
• W4386006145 cites W2003620839 @default.
• W4386006145 cites W2004801835 @default.
• W4386006145 cites W2004948940 @default.
• W4386006145 cites W2005245593 @default.
• W4386006145 cites W2008954479 @default.
• W4386006145 cites W2009167060 @default.
• W4386006145 cites W2009506760 @default.
• W4386006145 cites W2010973586 @default.
• W4386006145 cites W2011257826 @default.
• W4386006145 cites W2013759145 @default.
• W4386006145 cites W2014369677 @default.
• W4386006145 cites W2016983859 @default.
• W4386006145 cites W2017116606 @default.
• W4386006145 cites W2017462150 @default.
• W4386006145 cites W2017682578 @default.
• W4386006145 cites W2017941421 @default.
• W4386006145 cites W2018522328 @default.
• W4386006145 cites W2020112596 @default.
• W4386006145 cites W2020458122 @default.

• next